Table 5.
Clinical Trials Evaluating the Hypoglycemic Effect of Green Tea
| Clinical Trials | Subjects | Treatments | Size | Hypoglycemic effect | Jadad Score | Reference |
|---|---|---|---|---|---|---|
| Fukino Y et al. | Type 2 diabetic patients | Green tea extract containing 544mg polyphenols daily for 2 months | 66 | No | 1 | [49] |
| Mackenzie T et al. | Type 2 diabetic patients | 375 or 750mg green tea daily for 3 months | 49 | No | 2 | [50] |
| Nagao T et al. | Type 2 diabetic patients | 582.8 or 96.3mg catechin-containing green tea daily for 12 weeks | 43 | No | 0 | [51] |
| Hsu CH et al. | Type 2 diabetic patients | a daily dose of 1500 mg of green tea for 16 weeks | 80 | No | 3 | [52] |
| Fukino Y et al. | Healthy obese volunteers | A pack of green tea powder and extract containing 545mg catechins daily for 2 months | 60 | Yes/Noa | 2 | [53] |
| Venables MC et al. | Healthy volunteers | Green tea extract containing 890 mg polyphenols with moderate exercise | 23 | Yes | 0 | [54] |
| Brown AL et al. | Overweight/obese volunteers | 800 mg EGCG daily for 8 weeks | 88 | No | 4 | [55] |
| Josic J et al. | Healthy volunteers | 300ml of green tea | 14 | No | 1 | [56] |
One of the following four measurements was significantly different between the treatment and control group: FBS, HbA1c, postprandial glucose levels and area under curve of blood glucose.